Showing 1 - 10 of 13
Previous studies have suggested that medicines prices in Europe converge over time as a result of policy measures such …
Persistent link: https://www.econbiz.de/10010719286
To survey possible funding models and pricing practices as well as prices for the treatment package of trastuzumab and its accompanying diagnostic test in European countries, as an example of personalised medicines.
Persistent link: https://www.econbiz.de/10010719301
Cost-sharing for health care is high on the policy agenda in many European countries that struggle with deficits in their public budget. However, such policy often meets with public opposition, which might delay or even prevent its implementation. Increased reliance on patient payments may also...
Persistent link: https://www.econbiz.de/10011048310
The growing movement of innovative approaches to chronic disease management in Europe has not been matched by a …
Persistent link: https://www.econbiz.de/10011048313
This paper explores the goals and implementation of reforms introducing choice of and competition among insurers providing statutory health coverage in Belgium, Germany, the Netherlands and Switzerland. In theory, health insurance competition can enhance efficiency in health care administration...
Persistent link: https://www.econbiz.de/10010617065
assessed by AGREE) of clinical guidelines developed in Europe for the management of chronic diseases published since 2000. …
Persistent link: https://www.econbiz.de/10010580663
This review aimed to evaluate the effectiveness of strategies to implement clinical guidelines for chronic disease management in primary care in EU Member States.
Persistent link: https://www.econbiz.de/10010580672
Clinical guidelines are advocated to improve the quality of care, especially for chronic diseases. However, the regulatory basis of clinical guidelines, their development, quality control, implementation and use as well as evaluation within countries across the European Union is not...
Persistent link: https://www.econbiz.de/10010580676
In the absence of treatment and in the context of discrimination, HIV testing was embedded within exceptional procedures. With increasing treatment effectiveness, early HIV diagnosis became important, calling for the normalization of testing. National HIV testing policies were mapped to explore...
Persistent link: https://www.econbiz.de/10010577009
models is highly context-dependent. Yet Europe is highly diverse and we therefore argue the need for a strategic HHR …
Persistent link: https://www.econbiz.de/10010636231